Abstract:The Aurora-A kinase has well-established roles in spindle assembly and function and is frequently overexpressed in tumours. Its abundance is cell cycle regulated, with a peak in G2 and M phases, followed by regulated proteolysis at the end of mitosis. The microtubule-binding protein TPX2 plays a major role in regulating the activity and localisation of Aurora-A in mitotic cells. Here, we report a novel regulatory role of TPX2 and show that it protects Aurora-A from degradation both in interphase and in mitosis… Show more
“…All these features are also found in Aurora A null primary MEFs (15,31,32), which is consistent with the role of Tpx2 as a critical regulator of the Aurora A kinase (4,6,8,(33)(34)(35). However, some differences are detected between these 2 models suggesting separate functions.…”
Tpx2 is a microtubule-associated protein that activates the cell-cycle kinase Aurora A and regulates the mitotic spindle. Overexpression of Tpx2 is associated with the development of different human tumors and strongly correlates with chromosomal instability. By analyzing a conditional null mutation in the mouse Tpx2 gene, we show here that Tpx2 expression is essential for spindle function and chromosome segregation in the mouse embryo. Conditional genetic ablation of Tpx2 in primary cultures resulted in deficient microtubule nucleation from DNA and aberrant spindles during prometaphase. These cells eventually exited from mitosis without chromosome segregation. In addition, Tpx2 haploinsufficiency led to the accumulation of aneuploidies in vivo and increased susceptibility to spontaneous lymphomas and lung tumors. Together, our findings indicate that Tpx2 is essential for maintaining genomic stability through its role in spindle regulation. Subtle changes in Tpx2 expression may favor tumor development in vivo. Cancer Res; 72(6); 1518-28. Ă2012 AACR.
“…All these features are also found in Aurora A null primary MEFs (15,31,32), which is consistent with the role of Tpx2 as a critical regulator of the Aurora A kinase (4,6,8,(33)(34)(35). However, some differences are detected between these 2 models suggesting separate functions.…”
Tpx2 is a microtubule-associated protein that activates the cell-cycle kinase Aurora A and regulates the mitotic spindle. Overexpression of Tpx2 is associated with the development of different human tumors and strongly correlates with chromosomal instability. By analyzing a conditional null mutation in the mouse Tpx2 gene, we show here that Tpx2 expression is essential for spindle function and chromosome segregation in the mouse embryo. Conditional genetic ablation of Tpx2 in primary cultures resulted in deficient microtubule nucleation from DNA and aberrant spindles during prometaphase. These cells eventually exited from mitosis without chromosome segregation. In addition, Tpx2 haploinsufficiency led to the accumulation of aneuploidies in vivo and increased susceptibility to spontaneous lymphomas and lung tumors. Together, our findings indicate that Tpx2 is essential for maintaining genomic stability through its role in spindle regulation. Subtle changes in Tpx2 expression may favor tumor development in vivo. Cancer Res; 72(6); 1518-28. Ă2012 AACR.
“…26,40 Chemical inhibition of the proteasome rescued TPX2 and Aurora A abundance but incompletely recovered Aurora A activity in RHAMM-depleted cells. Thus, kinase activity required both abundance and the correct location of TPX2, and RHAMM was a necessary regulator for these 2 interdependent processes.…”
Section: Discussionmentioning
confidence: 99%
“…To test the possibility that the specific loss of RHAMM altered the stability of TPX2, the abundance of these proteins were determined in lysates from G 2 /M synchronized cell populations, as each gene product is strongly cell cycle regulated. 6,7,26 Synchronized populations of RHAMM-silenced cells showed reduced abundance of RHAMM and TPX2, but not the GTP binding protein Ran (Fig. 3E).…”
Section: Rhamm Localized To Centrosome and Non-centrosomal Spindle MImentioning
“…28,37,38 The mechanisms of activation of Aurora-A are still under deep investigation, although it is clear that TPX2 is a major regulator of its activity at different levels. TPX2 is involved in the localization of Aurora-A at the spindle, 17,31 stabilization of Aurora-A protein levels, 39 and achievement of appropriate levels of kinase activity. 20,21,40 The TPX2-Aurora-A binding occurs between the catalytic C-terminal part of the kinase and the N-terminal part of TPX2 (Fig.…”
Cell cycle deregulation is a common motif in human cancer, and multiple therapeutic strategies are aimed to prevent tumor cell proliferation. Whereas most current therapies are designed to arrest cell cycle progression either in G1/S or in mitosis, new proposals include targeting the intrinsic chromosomal instability (CIN, an increased rate of gain or losses of chromosomes during cell division) or aneuploidy (a genomic composition that differs from diploid) that many tumor cells display. Why tumors cells are chromosomally unstable or aneuploid and what are the consequences of these alterations are not completely clear at present. Several mitotic regulators are overexpressed as a consequence of oncogenic alterations, and they are likely to alter the proper regulation of chromosome segregation in cancer cells. In this review, we propose the relevance of TPX2, a mitotic regulator involved in the formation of the mitotic spindle, in oncogene-induced mitotic stress. This protein, as well as its partner Aurora-A, is frequently overexpressed in human cancer, and its deregulation may participate not only in chromosome numeric aberrations but also in other forms of genomic instability in cancer cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.